Transcriptome Profiling Reveals Indoxyl Sulfate Should Be Culpable of Impaired T Cell Function in Chronic Kidney

Fangfang Xiang1,2,3, Xuesen Cao1, Bo Shen1

  • 1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Indoxyl sulfate (IS), a uremic toxin, triggers chronic inflammation and DNA damage in T cells, potentially explaining complications in chronic kidney disease (CKD). This study reveals IS impacts T cell gene expression and function.

Area of Science:

  • Immunology
  • Nephrology
  • Toxicology

Background:

  • Chronic inflammation and immune dysfunction are key in chronic kidney disease (CKD) pathogenesis.
  • Uremic toxins, like indoxyl sulfate (IS), are implicated as a "missing link" in CKD complications.
  • The impact of IS on immune cell function, specifically T cells, remained largely unstudied.

Purpose of the Study:

  • To investigate the genome-wide gene expression profile of human peripheral T cells stimulated by IS.
  • To identify differentially expressed genes (DEGs) and understand IS's effects on T cell function.
  • To explore the role of IS as an endogenous ligand for the Aryl hydrocarbon receptor (AhR).

Main Methods:

  • RNA-sequencing transcriptome profiling of human peripheral T cells treated with IS in vitro.
  • Identification of differentially expressed genes (DEGs) in response to IS.
  • Validation of key findings using flow cytometry and western blot analysis.

Main Results:

  • Over 5129 DEGs were identified, with significant up- or down-regulation by IS, some concentration-specific.
  • IS stimulation altered T cell functional markers and transcription factor profiles.
  • IS upregulated Aryl hydrocarbon receptor (AhR) target genes and pro-inflammatory cytokines (TNF-α, IFN-γ), inducing DNA damage in T cells.

Conclusions:

  • IS exhibits toxicity to T cells, contributing to chronic inflammation in CKD.
  • As an AhR ligand, IS influences T cell inflammatory response and cell cycle regulation.
  • Further research is needed to elucidate mechanisms and develop strategies to preserve T cell function in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
454
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
463
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
720
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
263
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
409
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
224